What's new

Orphan designation: Adeno-associated viral vector serotype 3B encoding human multidrug resistance protein 3A Treatment of progressive familial intrahepatic cholestasis, 22/04/2020 Withdrawn

Orphan designation: Adeno-associated viral vector serotype 3B encoding human multidrug resistance protein 3A Treatment of progressive familial intrahepatic cholestasis, 22/04/2020 Withdrawn

Jun 10, 2025 - 08:25
 0
Orphan designation: Adeno-associated viral vector serotype 3B encoding human multidrug resistance protein 3A Treatment of progressive familial intrahepatic cholestasis, 22/04/2020 Withdrawn
Orphan designation: Adeno-associated viral vector serotype 3B encoding human multidrug resistance protein 3A Treatment of progressive familial intrahepatic cholestasis, 22/04/2020 Withdrawn
Read More

Tags:

Previous Article

Orphan designation: S-[5-(omega-methoxypoly(oxyethylene)-2-oxopentyl)]-L-cystein...

Next Article

Orphan designation: Nipocalimab Prevention of fetal and neonatal alloimmune thro...

Related Posts

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Betmiga, Mirabegron, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0085/2024

Opinion/decision on a Paediatric investigation plan (PI...

May 14, 2025  0